Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

 Rebetol (Ribavirin / Ribavirin and Intron A) Combination Therapy
Company:  Schering Corporation
Application No.:  020903s008, s011, s012 & s016
Approval Date: 7/25/2001


Date created: April 15, 2005

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.